Literature DB >> 28105185

LIM and SH3 protein 1 promotes tumor proliferation and metastasis in lung carcinoma.

Xueqiong Lin1, Xianhui Liu2, Yusen Fang1, Xuefen Weng1.   

Abstract

Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. In the present study, we focused on LIM and SH3 protein 1 (LASP-1), a key molecule involved in the development of multiple cancers, and attempted to elucidate its effect on the oncogenesis of lung cancer. We determined the expression level of LASP-1 in lung cancer using reverse transcription-quantitative polymerase chain reaction and western blot analysis, and also studied the potential function of LASP-1 in lung cancer cell growth, apoptosis and migration by small interfering RNA transfection. The results revealed that the levels of LASP-1 mRNA and protein were abnormally high in lung cancer cells. Following RNA interference of LASP-1, the proliferation and migration ability of the human cancer cell line A549 were significantly decreased. In addition, fluorescence-activated cell sorting analysis indicated that the apoptotic process in the A549 cell line was induced by the silencing of LASP-1. Our study is the first to investigate the potential of LASP-1 in lung cancer, and revealed its significant role in regulating the growth and metastasis of lung cancer cells. The present study suggests that LASP-1 has potential as a therapeutic target in the treatment of lung cancer in the clinic.

Entities:  

Keywords:  LIM and SH3 protein 1; RNAi; apoptosis; lung cancer

Year:  2016        PMID: 28105185      PMCID: PMC5228407          DOI: 10.3892/ol.2016.5225

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  A global map of p53 transcription-factor binding sites in the human genome.

Authors:  Chia-Lin Wei; Qiang Wu; Vinsensius B Vega; Kuo Ping Chiu; Patrick Ng; Tao Zhang; Atif Shahab; How Choong Yong; YuTao Fu; Zhiping Weng; JianJun Liu; Xiao Dong Zhao; Joon-Lin Chew; Yen Ling Lee; Vladimir A Kuznetsov; Wing-Kin Sung; Lance D Miller; Bing Lim; Edison T Liu; Qiang Yu; Huck-Hui Ng; Yijun Ruan
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

2.  Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.

Authors:  Thomas G P Grunewald; Ulrike Kammerer; Elfriede Schulze; Detlef Schindler; Arnd Honig; Michael Zimmer; Elke Butt
Journal:  Exp Cell Res       Date:  2006-01-23       Impact factor: 3.905

Review 3.  Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC).

Authors:  Nesaretnam Barr Kumarakulasinghe; Nico van Zanwijk; Ross A Soo
Journal:  Respirology       Date:  2015-02-17       Impact factor: 6.424

4.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Authors:  S Rodenhuis; R J Slebos; A J Boot; S G Evers; W J Mooi; S S Wagenaar; P C van Bodegom; J L Bos
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

Review 5.  Treatment of small cell lung cancer.

Authors:  Anupama Kurup; Nasser H Hanna
Journal:  Crit Rev Oncol Hematol       Date:  2004-11       Impact factor: 6.312

6.  Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.

Authors:  Liang Zhao; Hui Wang; Chao Liu; Yawei Liu; Xiaoyan Wang; Shuang Wang; Xuegang Sun; Jianming Li; Yongjian Deng; Yong Jiang; Yanqing Ding
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

7.  Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146.

Authors:  Elke Butt; Stepan Gambaryan; Nina Göttfert; Annette Galler; Katrin Marcus; Helmut E Meyer
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

8.  Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions.

Authors:  V Schreiber; C Moog-Lutz; C H Régnier; M P Chenard; H Boeuf; J L Vonesch; C Tomasetto; M C Rio
Journal:  Mol Med       Date:  1998-10       Impact factor: 6.354

9.  Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell.

Authors:  C S Chew; J A Parente; C Zhou; E Baranco; X Chen
Journal:  Am J Physiol       Date:  1998-07

10.  Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1.

Authors:  Bo Li; Lei Zhuang; Beat Trueb
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

View more
  5 in total

1.  MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.

Authors:  Yanmin Sui; Xiaolei Zhang; Honglan Yang; Wei Wei; Minglin Wang
Journal:  Oncol Rep       Date:  2017-11-27       Impact factor: 3.906

2.  Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.

Authors:  Xiupeng Zhang; Yang Liu; Chuifeng Fan; Liang Wang; Ailin Li; Haijing Zhou; Lin Cai; Yuan Miao; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Oncotarget       Date:  2017-08-24

3.  Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.

Authors:  Yu Lian; Fang Xiong; Liting Yang; Hao Bo; Zhaojian Gong; Yumin Wang; Fang Wei; Yanyan Tang; Xiayu Li; Qianjin Liao; Hui Wang; Ming Zhou; Bo Xiang; Xu Wu; Yong Li; Xiaoling Li; Xiang Chen; Guiyuan Li; Can Guo; Zhaoyang Zeng; Wei Xiong
Journal:  J Exp Clin Cancer Res       Date:  2018-10-16

4.  LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-β1/Smad/Snail Pathway.

Authors:  Qingming Xue; Hong Jiang; Jinjie Wang; Dongshan Wei
Journal:  Can Respir J       Date:  2021-12-06       Impact factor: 2.409

Review 5.  New Frontiers for the Cytoskeletal Protein LASP1.

Authors:  Elke Butt; Dayanidhi Raman
Journal:  Front Oncol       Date:  2018-09-21       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.